Skyla (levonorgestrel-releasing intrauterine system)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) April 2016 WARNINGS AND PRECAUTIONS Breast Cancer Observational studies of the risk of breast cancer with use of a LNG-releasing...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts